Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease [NA]
A completed clinical trial investigating immersive virtual reality bicycling for people with Parkinson's disease; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease [Phase 3]
A Phase 3 clinical trial update explores exenatide administered weekly for two years as a potential disease-modifying treatment for Parkinso…
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease [Phase 4]
Phase 4 trial update on cholinergic neurotransmission related to mobility and cognition in Parkinson disease and Parkinson disease dementia.
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: Feasibility and Preliminary Effects of MR-005 in Persons With Parkinson Disease [NA]
Feasibility and preliminary effects study of MR-005 in individuals with Parkinson disease has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) [Phase 2]
Phase 2 trial update for ENT-01 (oral) in Parkinson's disease-related constipation completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs) [Phase 1, Phase 2]
Clinical trial update for a randomized study in Parkinson's disease using pluripotent adipose stem cells (PASCs) in Phase 1/Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-11-30Clinical Trial Update: Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation [Phase 1, Phase 2]
Clinical trial updates on ENT-01 for Parkinson's Disease-related constipation report safety and tolerability data from Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2023-11-28Clinical Trial Update: Comparison of Dopamin Level in Idiopathic Parkinson's Patients [Phase 4]
A Phase 4 clinical trial update comparing dopamine levels in idiopathic Parkinson's patients; status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-11-27Clinical Trial Update: Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP) [Phase 3]
A Phase 3 clinical trial update for an apomorphine pump in early-stage Parkinson's disease is underway, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease [Phase 3]
Open-label Phase 3 trial evaluating long-term safety, tolerability, and efficacy of APL-130277 for acute treatment of OFF episodes in Parkin…
-
CLINICAL_TRIALS research · 2023-11-14Clinical Trial Update: Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression [Phase 2]
A Phase 2 clinical trial investigating clinical, imaging, and biologic markers to identify progression in Parkinson disease.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Manipulating and Optimizing Brain Rhythms for Enhancement of Sleep [NA]
A terminated clinical trial from Mayo Clinic investigating brain rhythm manipulation to enhance sleep, with posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) [Phase 3]
Phase 3 trial evaluating safety and tolerability of ABBV-951 in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-16Clinical Trial Update: A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients [Phase 3]
Phase 3 trial update assessing DaTSCAN Ioflupane SPECT imaging for diagnosing Parkinsonian syndromes in Chinese patients has completed with …
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Kick Out Parkinson's Disease- Karate Intervention [NA]
Clinical trial update for a karate intervention targeting Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson Disease [NA]
This trial result reports on the feasibility and effects of a strategy-based cognitive intervention for Parkinson disease, with the study co…
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease [Phase 2]
A Phase 2 randomized trial evaluating donepezil for mild cognitive impairment in Parkinson's disease is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients [Phase 2]
Phase 2 trial investigating the effect of folic acid in patients with Parkinson's disease treated with levodopa.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients [Phase 4]
Phase 4 trial update evaluating the impact of pharmacological treatments targeting energy metabolism on motor function in Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals With Parkinson's Disease [NA]
Completed study evaluating mental imagery training and its effects on brain plasticity and motor function in Parkinson's disease.
-
FDA label_change · 2023-09-15FDA Approved: NUPLAZID — Supplemental Application (Acadia Pharmaceuticals Inc.)
FDA approved Acadia's supplemental application for NUPLAZID (pimavanserin tartrate), resulting in an updated labeling for the product. The c…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Efficacy and Safety of Astragalus for Non-motor Symptoms of α-Synucleinopathy [Phase 2]
Phase 2 clinical trial assessing efficacy and safety of Astragalus for non-motor symptoms in α-synucleinopathy (Parkinsonism).
-
FDA approval · 2023-09-12FDA Approved: IOFLUPANE I 123 — Supplemental Application (Curium US LLC)
FDA approved a supplemental application for IOFLUPANE I-123 (DaTSCAN) from Curium US LLC.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Image Parkinson's Disease Progression Study [Phase 2]
A Phase 2 clinical trial on progression in Parkinson's disease has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Effectiveness and Implementation of the HiBalance Program in Clinical Practice [NA]
Clinical trial update on the HiBalance program for Parkinson's disease with completed status and posted results.